124 related articles for article (PubMed ID: 8713573)
1. Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.
Usuki K; Endo M; Osawa M; Kitazume K; Iki S; Urabe A
Int J Hematol; 1996 Jan; 63(1):19-23. PubMed ID: 8713573
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of low-dose all-trans retinoic acid in Japanese children with cancer.
Takitani K; Inoue A; Koh M; Kawakami C; Kuno T; Kawamura N; Miyake M; Tamai H
J Nutr Sci Vitaminol (Tokyo); 2004 Jun; 50(3):219-21. PubMed ID: 15386935
[TBL] [Abstract][Full Text] [Related]
5. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
Jpn J Cancer Res; 1995 Apr; 86(4):400-5. PubMed ID: 7775262
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
Castaigne S; Lefebvre P; Chomienne C; Suc E; Rigal-Huguet F; Gardin C; Delmer A; Archimbaud E; Tilly H; Janvier M
Blood; 1993 Dec; 82(12):3560-3. PubMed ID: 8260694
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Chen G; Shen Z; Zhu AP
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):295-9. PubMed ID: 10374268
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
Schwartz EL; Hallam S; Gallagher RE; Wiernik PH
Biochem Pharmacol; 1995 Sep; 50(7):923-8. PubMed ID: 7575674
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
12. [Experience in administration low dose all-trans retinoic acid for a child with acute promyelocytic leukemia].
Hata M; Nakayama T; Hattori T; Okano S; Ito T; Abe T; Kamakura M; Iinuma H; Okinaga K; Yasuda K
Rinsho Ketsueki; 1996 Feb; 37(2):129-33. PubMed ID: 8852030
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.
Adamson PC
Semin Hematol; 1994 Oct; 31(4 Suppl 5):14-7. PubMed ID: 7831580
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
Lanvers C; Reinhardt D; Dübbers A; Wagner-Bohn A; Creutzig U; Ritter J; Boos J
Med Pediatr Oncol; 2003 May; 40(5):293-301. PubMed ID: 12652617
[TBL] [Abstract][Full Text] [Related]
15. Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure.
Rajpurkar M; Alcasabas P; Warrier I; Valentini RP; Fassinger N; Frattarelli DA; Ravindranath Y
Pediatr Blood Cancer; 2007 Dec; 49(7):994-6. PubMed ID: 16609947
[TBL] [Abstract][Full Text] [Related]
16. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
Rigas JR; Francis PA; Muindi JR; Kris MG; Huselton C; DeGrazia F; Orazem JP; Young CW; Warrell RP
J Natl Cancer Inst; 1993 Dec; 85(23):1921-6. PubMed ID: 8230282
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia.
Lazzarino M; Regazzi MB; Corso A
Leuk Lymphoma; 1996 Nov; 23(5-6):539-43. PubMed ID: 9031084
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Agadir A; Cornic M; Lefebvre P; Gourmel B; Jérôme M; Degos L; Fenaux P; Chomienne C
J Clin Oncol; 1995 Oct; 13(10):2517-23. PubMed ID: 7595702
[TBL] [Abstract][Full Text] [Related]
20. [Induction and maintenance therapy in all-trans retinoic acid with relapsed acute promyelocytic leukemia].
Takitani K; Kawamura N; Yamaguchi H; Morinobu W; Yoshida N; Watanabe K; Miyake M; Tatsumi K; Mino M
Rinsho Ketsueki; 1995 Feb; 36(2):147-52. PubMed ID: 7715086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
